
MIRION TECHNOLOGIES INC
MIRNYSETrading Snapshot
- Day Range
- $15.20 โ $15.56
- 52-Week Range
- $14.11 โ $30.28
- Volume
- $1.66B
- Avg Volume
- $1.16B
- Shares Outstanding
- 243.3M
- Next Earnings
- Sep 7, 2026
Fundamentals Snapshot
- Annual Revenue
- $925M
- Last Q Revenue
- $267M
- P/E Ratio
- 154.3
- P/S Ratio
- 3.6x
- EPS (TTM)
- $0.10
- Dividend Yield
- 0.00%
Why Investors Own MIR
- โHigh-growth profile โ revenue up -9.8% YoY with expanding US Equity exposure.
- โHealthy economics โ 64% gross margin and 19% free-cash-flow margin.
- โNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About MIRION TECHNOLOGIES INC
Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).
Otter Score Breakdown
โAnalyst Ratings
โLatest News & Updates

Unlocking $50 Billion Across The Nuclear Value Chain
The DOE has selected five initial contenders after reviewing 28 applications from 26 states. The five states have signed memorandums of understanding to discuss potential hosting agreements.
Celestica shares are trading lower. The company reported its Q1 financial results.
Citigroup Maintains Buy on Mirion Technologies, Lowers Price Target to $24
Citigroup analyst Andrew Kaplowitz maintains Mirion Technologies (NYSE:MIR) with a Buy and lowers the price target from $28 to $24.
B. Riley Securities Maintains Buy on Mirion Technologies, Lowers Price Target to $27
B. Riley Securities analyst Yuan Zhi maintains Mirion Technologies (NYSE:MIR) with a Buy and lowers the price target from $29 to $27.

Mirion Technologies, Inc. (MIR) Q2 2026 Earnings Call Transcript
Mirion Technologies, Inc. (MIR) Q2 2026 Earnings Call July 29, 2026 10:00 AM EDTCompany ParticipantsEric Linn - Vice President of Investor RelationsThomas...

Mirion Technologies, Inc. 2026 Q2 - Results - Earnings Call Presentation
2026-07-29. The following slide deck was published by Mirion Technologies, Inc.